CEPI-backed Moderna vaccine enters Phase 1 trial against Ebola
By Abujah Racheal The Coalition for Epidemic Preparedness Innovations (CEPI) says the first participant has been dosed in a Phase 1 clinical trial of Moderna’s investigational vaccine against Bundibugyo ebolavirus. The milestone marks a significant step in efforts to develop a vaccine against the virus driving the ongoing Ebola outbreakContinue Reading



















